WNT3A and rheumatoid arthritis: Previously published studies have firmly established that numerous botanical-derived pharmaceuticals can effectively impede the proliferation, invasion, and migration of synovial fibroblast-like cells in RA through inhibition of the Wnt3a/β-catenin signaling pathway (32–35).